BACKGROUND: Dilated cardiomyopathy (DCM) is linked to inflammatory cardiomyopathy (InfCM). To gain a profound insight into the underlying mechanisms, we phenotypically characterized pan leukocytes (CD18), naive T-lymphocytes (CD3, CD2, CD4, CD8), activated lymphocytes (LFA-1, LFA-3, VLA-4, ICAM-1, CD69, CD45R0), macrophages (Mac-1, 27E10), B-lymphocytes (CD19) and NK-cells (CD57) in DCM and control hearts. MATERIAL/ METHODS: Biopsies from DCM patients (n=164, LVEF<40%) and specimens from non-cardiac death causes (controls; n=17) were immunostained. Biopsies exceeding >2.0 CD3+ lymphocytes per high power field/hpf and/or >1.5 CD3+ lymphocytes/hpf with numerous foci and HLA class I/DR abundance were evaluated positive for InfCM. RESULTS: InfCM+ biopsies (n=102; 63%) demonstrated significantly increased infiltrates with respect to all studied phenotypes except for CD19 and CD57 when compared with both DCM biopsies negative for InfCM (n=62) and the controls, whereas the latter two groups did not differ (Tukey-Kramer analysis). Virtually all phenotypes correlated with one another in multivariate analysis (except for B-lymphocytes and NK cells). Whereas HLA class I/DR abundance was present in 14% of the controls and 26% of the DCM biopsies not yielding InfCM, InfCM+ biopsies demonstrated significantly (<0.001) higher frequencies of HLA abundance (76%). CONCLUSIONS: The inflammatory process in InfCM comprises T-lymphocytes and macrophages, whereas B-lymphocytes and NK-cells are not significantly increased. InfCM is associated with HLA induction. CD69+, CD45R0+ and adhesion molecule bearing infiltrates indicate the activated state of lymphocytes, and 27E10 of macrophages in InfCM, respectively. Our data are in accordance with the hypothesis of a 'chronic active inflammatory process' involved in DCM.
BACKGROUND:Dilated cardiomyopathy (DCM) is linked to inflammatory cardiomyopathy (InfCM). To gain a profound insight into the underlying mechanisms, we phenotypically characterized pan leukocytes (CD18), naive T-lymphocytes (CD3, CD2, CD4, CD8), activated lymphocytes (LFA-1, LFA-3, VLA-4, ICAM-1, CD69, CD45R0), macrophages (Mac-1, 27E10), B-lymphocytes (CD19) and NK-cells (CD57) in DCM and control hearts. MATERIAL/ METHODS: Biopsies from DCMpatients (n=164, LVEF<40%) and specimens from non-cardiac death causes (controls; n=17) were immunostained. Biopsies exceeding >2.0 CD3+ lymphocytes per high power field/hpf and/or >1.5 CD3+ lymphocytes/hpf with numerous foci and HLA class I/DR abundance were evaluated positive for InfCM. RESULTS: InfCM+ biopsies (n=102; 63%) demonstrated significantly increased infiltrates with respect to all studied phenotypes except for CD19 and CD57 when compared with both DCM biopsies negative for InfCM (n=62) and the controls, whereas the latter two groups did not differ (Tukey-Kramer analysis). Virtually all phenotypes correlated with one another in multivariate analysis (except for B-lymphocytes and NK cells). Whereas HLA class I/DR abundance was present in 14% of the controls and 26% of the DCM biopsies not yielding InfCM, InfCM+ biopsies demonstrated significantly (<0.001) higher frequencies of HLA abundance (76%). CONCLUSIONS: The inflammatory process in InfCM comprises T-lymphocytes and macrophages, whereas B-lymphocytes and NK-cells are not significantly increased. InfCM is associated with HLA induction. CD69+, CD45R0+ and adhesion molecule bearing infiltrates indicate the activated state of lymphocytes, and 27E10 of macrophages in InfCM, respectively. Our data are in accordance with the hypothesis of a 'chronic active inflammatory process' involved in DCM.
Authors: Julius L Katzmann; Peter Schlattmann; Angelos G Rigopoulos; Ewa Noutsias; Boris Bigalke; Matthias Pauschinger; Carsten Tschope; Daniel Sedding; P Christian Schulze; Michel Noutsias Journal: Heart Fail Rev Date: 2020-03 Impact factor: 4.214
Authors: A Dörner; H-P Grunert; V Lindig; K Chandrasekharan; H Fechner; K U Knowlton; A Isik; M Pauschinger; H Zeichhardt; H-P Schultheiss Journal: J Mol Med (Berl) Date: 2006-08-05 Impact factor: 4.599
Authors: Pavanish Kumar; Amanda Lim; Su Li Poh; Sharifah Nur Hazirah; Camillus Jian Hui Chua; Nursyuhadah Binte Sutamam; Thaschawee Arkachaisri; Joo Guan Yeo; Theo Kofidis; Vitaly Sorokin; Carolyn S P Lam; Arthur Mark Richards; Salvatore Albani Journal: Front Immunol Date: 2022-03-15 Impact factor: 7.561